REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medinice S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Medical Laboratories
Full name: Medinice S.A. Profile Updated: November 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Medinice S.A is a Polish company. The company specializes in medical technology, focusing on low-invasive solutions in cardiology and cardiovascular surgery. Medinice S.A holds an ISO 13485 certificate and is planning to expand its activities by acquiring a company specializing in AI-based solutions.

Headquarters
ul. Stefana Hankiewicza 2
Warsaw; Mazowieckie; Postal Code: 02-103

Contact Details: Purchase the Medinice S.A. report to view the information.

Website: http://www.medinice.pl

Basic Information
Total Employees:
Purchase the Medinice S.A. report to view the information.
Outstanding Shares:
Purchase the Medinice S.A. report to view the information.
Registered Capital:
Purchase the Medinice S.A. report to view the information.
Financial Auditors:
Purchase the Medinice S.A. report to view the information.
Incorporation Date:
December 10, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
7.31%
Subsidiaries
Clip For Life Sp. z o.o.
100%
Medidata Sp. z o.o.
100%
Medinice B+R Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Medinice S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-3.42%▼
Total operating revenue
-11.02%▼
Operating profit (EBIT)
14.93%▲
EBITDA
14.85%▲
Net Profit (Loss) for the Period
12.25%▲
Total assets
-11.46%▼
Total equity
-11.51%▼
Operating Profit Margin (ROS)
309.79%▲
Net Profit Margin
211.2%▲
Return on Equity (ROE)
0.07%▲
Debt to Equity Ratio
0.69%▲
Quick Ratio
-24.05%▼
Cash Ratio
-23.72%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Helilab Sp. z o.o.
 
Henry Jones Sp. z o.o.
Cellis Sp. z o.o.
 
Redline Lab Group Sp. z o.o.
Miedzynarodowy Instytut Medycyny Translacyjnej
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo